Who owns Immunocore Holdings plc?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of IMCR from SEC Form 13F filings across 130 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 130 institutions disclosed 51.3M shares of Immunocore Holdings plc worth $1.55B — about 99.4% of shares outstanding; the largest disclosed holder is WELLINGTON MANAGEMENT GROUP LLP. Source: SEC Form 13F filings, parsed by EvidInvest.
130
13F holders
$1.55B
value, 2026 filers
99.4%
of shares outstanding (51.3M sh)
17
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of IMCR's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | WELLINGTON MANAGEMENT GROUP LLP | 5.7M | $173.1M | 0.0% | 11.1% | -0.1% |
| 2 | RTW INVESTMENTS, LP | 4.9M | $147.5M | 1.5% | 9.4% | 0.0% |
| 3 | PRIMECAP MANAGEMENT CO/CA/ | 3.6M | $110.1M | 0.1% | 7.1% | -0.1% |
| 4 | TANG CAPITAL MANAGEMENT LLC | 2.9M | $87.4M | 4.0% | 5.6% | +8.9% |
| 5 | Bellevue Group AG | 2.3M | $68.6M | 1.4% | 4.4% | -18.8% |
| 6 | TWO SIGMA INVESTMENTS, LP | 2.0M | $61.0M | 0.0% | 3.9% | +22.2% |
| 7 | ACADIAN ASSET MANAGEMENT LLC | 1.8M | $55.2M | 0.1% | 3.5% | +50.8% |
| 8 | FMR LLC | 1.7M | $52.6M | 0.0% | 3.4% | -59.7% |
| 9 | Caligan Partners LP | 1.7M | $50.6M | 3.1% | 3.2% | +21.1% |
| 10 | Kynam Capital Management, LP | 1.4M | $41.6M | 2.3% | 2.7% | 0.0% |
| 11 | Point72 Asset Management, L.P. | 1.3M | $38.1M | 0.0% | 2.4% | +27.0% |
| 12 | BVF INC/IL | 1.2M | $37.3M | 1.2% | 2.4% | -4.9% |
| 13 | MPM BIOIMPACT LLCNEW | 1.2M | $36.4M | 2.7% | 2.3% | new |
| 14 | ARMISTICE CAPITAL, LLC | 1.1M | $34.4M | 0.4% | 2.2% | -20.4% |
| 15 | Trails Edge Capital Partners, LP | 1.1M | $32.2M | 4.6% | 2.1% | 0.0% |
| 16 | BlackRock, Inc. | 1.0M | $31.7M | 0.0% | 2% | +4.3% |
| 17 | FARALLON CAPITAL MANAGEMENT, L.L.C.NEW | 928,000 | $28.1M | 0.1% | 1.8% | new |
| 18 | BRAIDWELL LP | 906,115 | $27.4M | 1.1% | 1.8% | +73.8% |
| 19 | Janus Henderson Group Ltd.NEW | 868,112 | $26.3M | 0.0% | 1.7% | new |
| 20 | Vestal Point Capital, LP | 850,000 | $25.7M | 0.7% | 1.6% | -52.8% |
| 21 | MILLENNIUM MANAGEMENT LLC | 839,258 | $25.4M | 0.0% | 1.6% | -47.4% |
| 22 | Frazier Life Sciences Management, L.P. | 829,752 | $25.1M | 0.6% | 1.6% | +71.2% |
| 23 | MARSHALL WACE, LLP | 614,728 | $18.6M | 0.0% | 1.2% | +4.0% |
| 24 | D. E. Shaw & Co., Inc. | 561,415 | $17.0M | 0.0% | 1.1% | +38.6% |
| 25 | Hudson Bay Capital Management LP | 535,000 | $16.2M | 0.0% | 1% | -9.3% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.